Logo-jrip
J Renal Inj Prev. 2018;7(3): 139-143. doi: 10.15171/jrip.2018.35

Review

Regional citrate anticoagulation for continuous renal replacement therapy without post-filter monitoring of ionized calcium

Tibor Fülöp 1 * , Sohail Abdul Salim 1, Lajos Zsom 2

Cited by CrossRef: 4


1- Ma Y, Qiao X, Lu Q, Li R, Bai Y, Li X, Zhang S, Gong Y. Anchorable phosphorylcholine copolymer synthesis and cell membrane mimetic antifouling coating fabrication for blood compatible applications. J Mater Chem B. 2020;8(19):4299 [Crossref]
2- Fülöp T, Zsom L, Rodríguez R, Chabrier-Rosello J, Hamrahian M, Koch C. Therapeutic hypernatremia management during continuous renal replacement therapy with elevated intracranial pressures and respiratory failure. Rev Endocr Metab Disord. 2019;20(1):65 [Crossref]
3- Fang D, Chabrier-Rosello J, McMahon B, Fülöp T, Achanti A. Achieving Osmotic Stability in the Context of Critical Illness and Acute Kidney Injury During Continuous Renal Replacement Therapy. 2020;66(7):e90 [Crossref]
4- Thanapongsatorn P, Sinjira T, Kaewdoungtien P, Kusirisin P, Kulvichit W, Sirivongrangson P, Peerapornratana S, Lumlertgul N, Srisawat N. Standard versus no post-filter ionized calcium monitoring in regional citrate anticoagulation for continuous renal replacement therapy (NPC trial). 2023;16(9):1469 [Crossref]